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ABSTRACT
Introduction: The fetal pillow has been suggested to reduce maternal trauma and fetal adverse 
outcomes when used to disimpact the fetal head at full dilatation cesarean section. Material and 
methods: We performed a retrospective cohort study of the use of the fetal pillow device at full 
dilatation cesarean section between September 2014 and March 2018 at Liverpool Women’s 
Hospital, a large UK teaching hospital. Results: There were 471 cases of full dilatation cesarean 
section during the study period and 391 were included for the analysis; 170 used the fetal pillow 
and 221 cases were delivered without. We did not demonstrate any benefit in the significant 
maternal outcomes of; estimated blood loss >1000ml or >1500ml, need for blood transfusion or 
duration of hospital stay, from the use of the fetal pillow. We did not demonstrate any 
improvement in fetal outcome following use of the fetal pillow; arterial pH <7.1, apgar score <7 at 
5 mins or admission to the neonatal unit. For deliveries undertaken at or below the level of the 
ischial spines there was likewise no benefit from fetal pillow use except in a reduced risk of an 
arterial pH <7.1 (0.39 (0.20 - 0.80), 0.0094) however admission to the neonatal unit was 
unaffected. Conclusions: This is the largest study to date on the use of the fetal pillow at full 
dilatation cesarean section. We did not demonstrate any statistically significant benefit from the 
use of the fetal pillow to prevent any of maternal or fetal adverse outcomes at full dilatation 
cesarean section in routine clinical use. Further randomised studies are required to prove clinical 
benefit from this device prior to more widespread use.
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The use of the fetal pillow at full dilatation cesarean section appears to be ineffective at reducing 
significant maternal or fetal complications.
INTRODUCTION
Cesarean section at full cervical dilatation (FDCS) occurs in 1.24-2.1% of all deliveries (1, 2) and 
is associated with both maternal and fetal complications, including maternal trauma and low cord 
pH (3). With the rate of cesarean section continuing to rise and some concerns raised about 
reducing skills in complex instrumental delivery, it is likely that this trend will continue.
The fetal pillow is a one-use disposable silicone device consisting of a soft flat base with a balloon 
compartment, which can be inserted into the vagina and then inflated in order to elevate the fetal 
head prior to FDCS (Safe Obstetric Systems, Essex, UK). The use of the fetal pillow has been 
suggested to reduce maternal trauma from bleeding and uterine or vaginal tears at FDCS (4). 
However, a recent meta-analysis of the limited data available suggests that reverse breech 
extraction for delivery of the fetus at FDCS is superior to vaginal push methods. The authors of 
this review were unable to formally assess the use of fetal pillow due to a lack of evidence (5).
Use of the fetal pilow has been suggested to reduce blood loss, improve cord pH and reduce 
duration of hospital admission when compared to no manipulation or elevation of the fetal head 
manually by an assistant with their hand within the vagina (6, 7). A recent study also suggested 
that fetal pillow usage reduced hospital stay by 9 hours (8). A subsequent randomised controlled 
trial did suggest that use of the fetal pillow at FDCS reduced the incidence of uterine extensions 
but no other outcome (4). 
This study was designed to review whether use of the fetal pillow at FDCS reduced estimated 












This article is protected by copyright. All rights reserved
We performed a retrospective cohort study of all cases where a cesarean section for a singleton 
pregnancy was performed at full dilatation between September 2014 and March 2018 at Liverpool 
Women’s Hospital, a large UK teaching hospital. Each case was categorised by whether a fetal 
pillow was or was not used. All outcomes were obtained from the hospital electronic patient 
record systems Meditech and neonatal outcomes from Badger.net.
The fetal pillow was introduced at Liverpool Women’s Hospital as an option for the management 
of FDCS in September 2014. All senior trainees and consultants were fully trained in the use of 
the fetal pillow, FDCS and rotational vaginal deliveries. The decision to use a fetal pillow or not 
was left to the individual clinician.
Statistical analysis was performed using a t-test for normally distributed values and relative risk 
when comparing between interventions.
Ethical approval
Ethical approval was provided as part of hospital audit processes on 2 June 2015 (Liverpool 
Women’s Hospital 2016/016).
RESULTS
There were 471 cases of FDCS during the study period. We excluded 70 cases; 48 twin 
pregnancies, 18 breech presentation, 13 had been misreported as being at full dilatation and a 
single antepartum stillbirth. This left 391 cases for assessment of which 170 had used a fetal 
pillow and 221 where a fetal pillow had not been used. 
There were no significant differences between the groups in maternal age, BMI, ethnicity, onset of 
labour or fetal position. There were statistical differences in station with fewer fetal pillow cases 
reported as above (relative risk: 0.37 (95% confidence interval: 0.25 – 0.57); p<0.0001) and more 
below the ischial spines (2.34 (1.68 – 3.26); <0.0001). There were more nulliparous women 
managed with fetal pillow (1.19 (1.08 – 1.31); 0.0009) (Table 1).
Maternal outcomes such as estimated blood loss; haemorrhage >1000ml (1.24 (0.84-1.83); 0.29) 









This article is protected by copyright. All rights reserved
need for blood transfusion (1.16 (0.46-2.90; 0.76) were not influenced by the use of the fetal 
pillow. Likewise time to discharge was unaffected by fetal pillow usage (Table 2).
All neonates were born alive during the study period irrespective of fetal pillow usage. There was 
no statistical difference in neonatal outcomes by use of fetal pillow for apgar score <7 at 5 minutes 
(1.30 (0.60 - 2.82); 0.51) and admission to the neonatal unit (0.72 (0.40-1.31); 0.29) (Table 3). 
There was no statistically significant effect on  arterial pH <7.1 in those neonates managed with 
fetal pillow compared to those without fetal pillow (0.54 (0.28-1.02; 0.06)). There were no 
episodes of fetal skull fracture or other birth trauma in the study period. 
We further assessed those deliveries potentially thought to be most likely to benefit from the use 
of the fetal pillow, namely those at or below the level of the ischial spines (fetal pillow used 139, 
no fetal pillow 126) (Table 4) or below the ischial spines (fetal pillow used 72, no fetal pillow 40 
(Table 5). There was no benefit from the use of the fetal pillow on maternal outcomes of; 
estimated blood loss >1000ml either at the spines or below (1.61 (0.95 - 2.72), 0.0747) or below 
the spines (2.78 (0.64 - 12.06), 0.1726). There was no reduction in estimated blood loss >1500ml 
either at the spines (2.72 (0.90 - 8.22), 0.0761) or below the spines (2.22 (0.26 - 19.21), 0.726). 
There was no effect upon the need for maternal blood transfusion either at the spines (1.81 (0.56 - 
5.88), 0.3213) or below the spines (2.22 (0.26 - 19.21), 0.726). There was no effect on the 
frequency of uterine extensions when the fetal head was at the spines or below (0.87 (0.56 – 1.36), 
0.56) or when it was below the spines (0.90 (0.41 – 1.99), 0.80). 
Fetal outcomes from use of the fetal pillow at or below the ischial spines showed no effect on 
apgar score <7 at 5 minutes (1.30 (0.51 - 3.30), 0.5881), or admission to the neonatal unit (0.67 
(0.31 - 1.39), 0.2793), but did reduce the chance of the neonate being born with an arterial pH <7.1 
(0.39 (0.20 - 0.80), 0.0094). There was no benefit in outcome from fetal pillow usage when station 
was below the spines for apgar score <7 at 5 minutes (3.33 (0.42 – 26.72), 1.134), neonatal 
admission (0.78 (0.26 - 2.29), 0.6485) or arterial pH <7.1 (0.56 (0.23 - 1.37), 0.2008). 
DISCUSSION
The management of the fetus that does not deliver vaginally after full dilatation represents a 
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use of FDCS with its associated morbidity rather than more complex vaginal deliveries (9). It is 
therefore attractive to look to devices such as the fetal pillow to improve clinical outcomes in these 
cases. 
Our study represents the largest study to date on the routine clinical use of the fetal pillow to assist 
delivery of the fetus at FDCS.We were not able to demonstrate any clinically relevant benefit from 
the use of the fetal pillow over normal methods either in maternal outcomes such as haemorrhage 
or in fetal outcomes. There was no benefit when the presenting part was at the level of the ischial 
spines or lower, suggesting a more deeply impacted fetal head. The only factor reaching statistical 
significance was a reduction in low arterial pH with fetal pillow use but without a concomitant 
reduction in admission to the neonatal unit it is unclear what if any clinical relevance there is from 
this. Our findings are consistent with those of Hanley et al. but we were not able to identify a 
meaningful difference in length of hospital stay.
The limitations of our study include its non-randomised, retrospective nature and as such there 
may be some unknown factors about patient selection. It is perfectly plausible that patient 
selection on who received the fetal pillow on had an influence on these findings as demonstrated 
by the increased usage of the fetal pillow when station was below the Ischial Spines. Likewise, we 
did not assess clinician experience although due to the size and duration of the study the authors 
feel this is unlikely to have been a major influencing factor. However, this study is large and does 
reflect the experience of routine clinical use of the fetal pillow within a large UK maternity unit 
where usage of the fetal pillow was well established. There were more nulliparous women in the 
fetal pillow group than in those managed without and this may have been an influencing factor on 
the decision to use the fetal pillow, although it is unclear what effect this would have had on the 
main outcome measures of haemorrhage and neonatal adverse outcome. Further limitations of this 
study include a higher number of deliveries for fetal distress in the non-fetal pillow group, which 
may have influenced the decision not to use the fetal pillow, although as there was no difference in 
apgar score or neonatal intensive care unit admission it is unlikely to reflect true fetal compromise. 
The only randomised study of fetal pillow use demonstrated a significant difference in blood loss 
>1000ml, need for blood transfusion and in surgeon grading of major uterine extension at cesarean 
section (4). We observed no effect on uterine extensions between those women managed with a 
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CONCLUSION
We demonstrate the largest study of use of the fetal pillow at FDCS. Our data did not demonstrate 
any significant clinical improvement in maternal outcomes related to clinically important features 
of blood loss, transfusion, uterine extensions or hospital stay. The only improvement in neonatal 
outcome with the use of the fetal pillow was less cases of arterial pH <7.10 where the pillow was 
used at or below the ischial spines, but without a concomitant effect on apgar score or neonatal 
unit admission making interpretation of the value of this finding difficult. Furthermore, when 
looking at the use of the fetal pillow in cases of a presumed deeply impacted head below the 
ischial spines even this positive finding was no longer present, although in these subgroups the 
data is limited and confidence intervals are wide. 
We suggest that clinician preference should guide the use of fetal pillow at FDCS, further guided 
by local considerations of healthcare costs and service demands. Only when sufficient 
effectiveness and safety data is available would routine use be justified. 
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Legends
Figure 1. Selection of cases for assessment. FDCS, full dilatation cesarean section; LWH, 
Liverpool Women’s Hospital.
Table 1: Population characteristics by use of fetal pillow.
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Table 3: Fetal and neonatal outcomes by use of fetal pillow.
Table 4: Maternal and fetal outcomes for deliveries at the ischial spines or lower.
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 Fetal Pillow  
(n= 170) 
n (%) 




P value or RR 
 
Age 




(27 – 33) 
 
30 
(27 – 34) 
 








(22.9 – 28.5) 
 
25.7  
(23.1 – 29.5) 
 
P = 0.31 
 


































1.19 (1.08 – 1.31); 0.0009 
 






































1.23 (0.80 – 1.88); 0.3428 
0.98 (0.77 – 1.23); 0.8300 
1.05 (0.80 – 1.39); 0.7081 
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0.37 (0.25 – 0.57); <0.0001 
1.01 (0.79 – 1.30); 0.9203 
2.34 (1.68 – 3.26); <0.0001 
0.69 (0.30 – 1.60); 0.3897 
 
Indication for CS: 
Failed instrumental 
Fetal distress 




















1.90 (1.36 – 2.66); <0.0001 
0.37 (0.21 – 0.65); 0.0005 
1.06 (0.88 – 1.29); 0.5274 
0.31 (0.08 – 1.16); 0.0807 
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 Fetal Pillow  
(n= 170) 
No Fetal Pillow  
(n=221) 
Relative Risk (95% CI) 
 
Estimated blood loss 
(ml; median, quartiles) 
 
600 








Estimated blood loss >1000ml 
n (%) 
 






1.24 (0.84 - 1.83); 0.29 
 
 

























1.02 (0.70 – 1.50); 0.91 
 





(2 – 3) 
 
2 












Table 2: Maternal outcomes by use of fetal pillow 
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Table 3: Fetal and neonatal outcomes by use of fetal pillow 
 
NICU, neonatal intensive care unit. 
 Fetal Pillow  
(n= 170) 
No Fetal Pillow  
(n=221) 




(grams; median, Quartile) 
 
3658  
(3350 - 3958) 
 
3650 











1.30 (0.60 - 2.82); 0.51 
 







0.54 (0.28 - 1.02); 0.06 
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 Fetal Pillow  
(n= 139) 




Estimated blood loss 
(ml; median, quartiles) 
 
600 
(500 – 887.5) 
 
600 











1.61 (0.95 - 2.72), 0.07 
 

























0.87 (0.56 – 1.36), 0.56 
 








1.30 (0.51 - 3.30), 0.59 
Arterial pH <7.1 
n (%) 
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Table 4: Maternal and fetal outcomes for deliveries at the ischial spines or lower 
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 Fetal Pillow  
(n= 72) 
No Fetal Pillow   
(n=40) 
Relative Risk (95% CI); p 
 
Estimated blood loss 
(ml; median, quartiles) 
 
600 
(500 – 900) 
 
600 











2.78 (0.64 - 12.06); 0.17 
 

























0.90 (0.41 – 1.99); 0.80 
 








3.33 (0.42 – 26.72); 1.13 
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Table 5: Maternal and fetal outcomes for deliveries below the ischial spines  





0.78 (0.26 - 2.29); 0.65 
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